NDA Partners is a United States based life sciences management consulting and contract development organization (CDO) operating within the healthcare industry. Founded in 2003, the company specializes in offering product development and regulatory services to the pharmaceutical, biotechnology, and medical device sectors globally. Notably, the team at NDA Partners comprises highly experienced Principals and Expert Consultants, including three former FDA Center Directors, the former CEO and CSO at the US Pharmacopeial Convention (USP), and an international team of over 100 former pharmaceutical industry and regulatory agency senior executives. Additionally, the organization boasts an extensive roster of highly proficient experts in a variety of specialized areas, such as nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. NDA Partners offers a range of services, including product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management. As of now, specific details regarding the last investment and investors involved are unavailable.
There is no investment information
No recent news or press coverage available for NDA Partners.
We care about your data, and we'd love to use cookies make your experience better.
